Medicine and Science, that's me! My name is Giusy Davino and I'm just a 22-years-old medical student in University of Salerno (Italy) with internet access!
"Isn't it strange
That princes and kings
And clowns that caper
In sawdust rings
And common people
Like you and me
Are builders for eternity?
Each is given a bag of tools,
A shapeless mass,
A book of rules;
And each must make -
Ere life is flown -
A stumbling block
Or a stepping stone."

 

jewsee-medicalstudent:

Aortic Coarctation.

These are MRI and MRA images of a 22-year-old man with aortic coarctation, a congenital condition whereby the aorta narrows in the area where the ductus arteriosus (ligamentum arteriosum after regression) inserts and it is considered when a section of the aorta is narrowed to an abnormal width.

Coarctation is a congenital anomaly of unknown etiology that results in a focal obstruction at the junction of the distal aortic arch and descending thoracic aorta. It is responsible for 6% of congenital cardiac anomalies. Although there is blood flow across the coarc segment, it is supplemented by collateral blood flow that bypasses the obstruction via intercostal, internal mammary, epigastric, spinal, and periscapular arteries.

It is rare before 10-years of age and is most pronounced along the posterior upper ribs. Prognosis is good with early surgical intervention, poor without surgical intervention; very high mortality rate by 6th decade of life in this subset of patients.

(Images and clinical informations via VCU Medical Center).

sparklingradish:

I found some of the “notes”/study guides I drew for the Anatomy class I took three or four years ago. Maybe these diagrams can be useful to someone else!

Most of the drawings are labeled with directionals — A/P for Anterior and Posterior, R/C for Rostral/Caudal, and I/S for Inferior/Superior. Circle with the dot means coming toward you, circle with the x means going away from you.

craigmiller2014 asked
Hi, My name is Craig I'M 23 from Liverpool, England. I also am involved in hepatology and gastroenterology, what health subjects do you enjoy? Also I am new to this Tumblr thing lol, so could you help me on how to use it :) Thanks

Hi Craig, nice to meet you! I like gastroenterology and hepatology a lot too, but also cardiology and internal medicine.
Tumblr is perfect for following people that write about things you are interested in most and if you follow someone, his posts will appear in your dashboard where you can read them :) I hope you have fun here!

asapscience:

Unfortunately, this is American Ebola logic. 
For more on the hysteria surrounding Ebola, we recommend listening to this week’s episode of NPR’s On The Media to help dispel fears. 
(@SciencePorn)

asapscience:

Unfortunately, this is American Ebola logic. 

For more on the hysteria surrounding Ebola, we recommend listening to this week’s episode of NPR’s On The Media to help dispel fears. 

(@SciencePorn)

biocanvas:

Human fibroblasts
Fibroblasts are cells that help maintain tissue structure by secreting proteins like collagen and elastin. Because they are easy to acquire and maintain in a laboratory, fibroblasts are one of the most common starting points for induced pluripotent stem cells (iPSCs), which are adult cells like fibroblasts that have been coaxed to return to a very early stem cell state. iPSCs have the potential to become almost any cell in the human body, making them prime candidates for regenerative medicine, but creating them is incredibly inefficient. To help generate iPSCs, recent research has looked towards separating out iPSCs based on how adhesive they are compared to other cells. In this image, fibroblasts (magenta) express a cell adhesion protein (green), which can be used to determine differences in stickiness between cells.
Image by Dr. Ankur Singh, Cornell University.

biocanvas:

Human fibroblasts

Fibroblasts are cells that help maintain tissue structure by secreting proteins like collagen and elastin. Because they are easy to acquire and maintain in a laboratory, fibroblasts are one of the most common starting points for induced pluripotent stem cells (iPSCs), which are adult cells like fibroblasts that have been coaxed to return to a very early stem cell state. iPSCs have the potential to become almost any cell in the human body, making them prime candidates for regenerative medicine, but creating them is incredibly inefficient. To help generate iPSCs, recent research has looked towards separating out iPSCs based on how adhesive they are compared to other cells. In this image, fibroblasts (magenta) express a cell adhesion protein (green), which can be used to determine differences in stickiness between cells.

Image by Dr. Ankur Singh, Cornell University.

(Source: olympusbioscapes.com)

dnrgm asked
heey! :) i just signed up on tumblr. and the first thing i saw was your blog. i guess today's my lucky day. i'm a medical student-in 4th grade- too. and recently i've been thinking about erasmus in italy. could you tell me a bit about medical education in your country?

Hi dear, sorry if I reply now but I am sooooo busy with courses and university! I’m really glad that you are thinking about Erasmus, I think it is such a great experience, I wish I was brave enough too to go in another country for such long times (I’m so emotional, I would miss everyone!) :) anyway, I think that the main difference between Italy and other countries is that here exams are almost all oral, or they are tests + oral examinations, but I don’t know if it’s the same for foreign students here in Erasmus. Except this, I think that you’ll have a great time in Italy, you’ll literally fall in love. Good luck for all!

WHO chooses an Italian vaccine against Ebola.
Conceived and implemented by the Italian company Okairos, in cooperation with the American National Institute of Health (NIH), the development of a new experimental Ebola vaccine was carried out by a joint-venture between the Italian company and IRBM.
Previous tests conducted on animal models in the USA showed “outstanding results” – spokesmen from the company explained –, while clinical trials on humans approved by the Food and Drug Administration (FDA) began in late August in the USA and United Kingdom. One shot of vaccine made from two Ebola virus gene segments incorporated into a chimpanzee cold virus vector (called chimp adenovirus type 3 or ChAd3) protected all four macaque monkeys exposed to high levels of Ebola virus 5 weeks after inoculation.
The vaccine results from a multiannual research carried out by Professor Riccardo Cortese, one of the most brilliant scientist in the field worldwide. He cooperated with his team for the development of a “hybrid” novel technology aimed at merging immunotherapy with gene therapy, which led to important pharmaceutical findings in diseases in which traditional methods always failed.
(To read more: researchitaly; sciencedaily).

WHO chooses an Italian vaccine against Ebola.

Conceived and implemented by the Italian company Okairos, in cooperation with the American National Institute of Health (NIH), the development of a new experimental Ebola vaccine was carried out by a joint-venture between the Italian company and IRBM.

Previous tests conducted on animal models in the USA showed “outstanding results” – spokesmen from the company explained –, while clinical trials on humans approved by the Food and Drug Administration (FDA) began in late August in the USA and United Kingdom. One shot of vaccine made from two Ebola virus gene segments incorporated into a chimpanzee cold virus vector (called chimp adenovirus type 3 or ChAd3) protected all four macaque monkeys exposed to high levels of Ebola virus 5 weeks after inoculation.

The vaccine results from a multiannual research carried out by Professor Riccardo Cortese, one of the most brilliant scientist in the field worldwide. He cooperated with his team for the development of a “hybrid” novel technology aimed at merging immunotherapy with gene therapy, which led to important pharmaceutical findings in diseases in which traditional methods always failed.

(To read more: researchitaly; sciencedaily).

neuromorphogenesis:

UNDERSTANDING THE PHENOMENON OF SYNESTHESIA

The number 3 is color orange and January is moody, according to synesthetes. They are blessed with the natural ability, thought to be passed on by genes, of a blending of senses, in which the brain’s sensory centers remain connected on two levels.

by MEZZMER

Anonymous asked
hello i love your blog it is really cool :) imm i want ask you something when did you start in med school i mean how old were you ? :)

Hello dear anon, thank you so much!
I started med school at 19 years old (this is the age at whom boys and girls are going to start university in Italy) and now I’m 22 and I’m going to start 4th year in October. Good luck for all!

First lung dialysis successfully tested in Italy.
Lung dialysis to help treat Chronic obstructive pulmonary disease (COPD) was successfully tested in Italy on Wednesday for the first time in the world. The new method, which was tested at Molinette hospital in Turin and Sant’ Orsola hospital in Bologna, could significantly reduce mortality rates, a statement from Molinette hospital said.
COPD is a type of obstructive lung disease characterized by chronically poor airflow. It typically worsens over time. The main symptoms include shortness of breath, cough, and sputum production. Most people with chronic bronchitis have COPD and it is mainly caused by pollution and cigarette smoke.
Normally, when COPD patients experience severe breathing difficulties, they are treated with non-invasive ventilation, consisting of masks which pump air into the lungs to remove carbon dioxide. But when non-invasive ventilation fails, which happens in 25-50 percent of cases, they need to be connected to a ventilator through a tube, which is called invasive ventilation, and the risk of death increases up to 100 times.
The new method of lung dialysis, which was created and manufactured in Italy, is a low-invasive system that purifies the patients’ blood by reducing carbon dioxide level, the statement said.
(To read more).

First lung dialysis successfully tested in Italy.

Lung dialysis to help treat Chronic obstructive pulmonary disease (COPD) was successfully tested in Italy on Wednesday for the first time in the world. The new method, which was tested at Molinette hospital in Turin and Sant’ Orsola hospital in Bologna, could significantly reduce mortality rates, a statement from Molinette hospital said.

COPD is a type of obstructive lung disease characterized by chronically poor airflow. It typically worsens over time. The main symptoms include shortness of breath, cough, and sputum production. Most people with chronic bronchitis have COPD and it is mainly caused by pollution and cigarette smoke.

Normally, when COPD patients experience severe breathing difficulties, they are treated with non-invasive ventilation, consisting of masks which pump air into the lungs to remove carbon dioxide. But when non-invasive ventilation fails, which happens in 25-50 percent of cases, they need to be connected to a ventilator through a tube, which is called invasive ventilation, and the risk of death increases up to 100 times.

The new method of lung dialysis, which was created and manufactured in Italy, is a low-invasive system that purifies the patients’ blood by reducing carbon dioxide level, the statement said.

(To read more).

medicalschool:

The Human Heart
Volume Rendering of a contrast enhanced cardiac CT

medicalschool:

The Human Heart

Volume Rendering of a contrast enhanced cardiac CT

Superior vena cava syndrome.
Superior vena cava syndrome (SVCS), is a group of symptoms caused by obstruction of the superior vena cava. More than 90% of cases of superior vena cava obstruction are caused by cancer - most commonly bronchogenic carcinoma, typically a tumor outside the vessel compressing the vessel wall - but it can, sometimes, have a benign cause.
Signs and symptoms: Shortness of breath is the most common symptom, followed by face or arm swelling due to excess of fluid (edema). Frequent symptoms are: headache, venous distention in the neck and distended veins in the upper chest and arms, lightheadedness, cough.
Treatment: Several methods of treatment are available, mainly consisting of careful drug therapy and surgery. Glucocorticoids (such as prednisone or methylprednisolone) decrease the inflammatory response to tumor invasion and edema surrounding the tumor. They are most helpful if the tumor is steroid-responsive, such as lymphomas. In addition, diuretics (such as furosemide) are used to reduce venous return to the heart which relieves the increased pressure.
(Picture from The New England Journal of Medicine).

Superior vena cava syndrome.

Superior vena cava syndrome (SVCS), is a group of symptoms caused by obstruction of the superior vena cava. More than 90% of cases of superior vena cava obstruction are caused by cancer - most commonly bronchogenic carcinoma, typically a tumor outside the vessel compressing the vessel wall - but it can, sometimes, have a benign cause.

Signs and symptomsShortness of breath is the most common symptom, followed by face or arm swelling due to excess of fluid (edema). Frequent symptoms are: headache, venous distention in the neck and distended veins in the upper chest and arms, lightheadedness, cough.

Treatment: Several methods of treatment are available, mainly consisting of careful drug therapy and surgery. Glucocorticoids (such as prednisone or methylprednisolone) decrease the inflammatory response to tumor invasion and edema surrounding the tumor. They are most helpful if the tumor is steroid-responsive, such as lymphomas. In addition, diuretics (such as furosemide) are used to reduce venous return to the heart which relieves the increased pressure.

(Picture from The New England Journal of Medicine).